Donor intra-islet endothelial cells contribute to neovascularization after transplantation. Several factors may interfere with this process and ultimately influence islet engraftment. Rapamycin, a central immunosuppressant in islet transplantation, is an mTOR inhibitor that has been shown to inhibit cancer angiogenesis. The aim of this study was to evaluate the effects of rapamycin on islet endothelium. Rapamycin inhibited the outgrowth of endothelial cells from freshly purified human islets and the formation of capillary-like structures in vitro and in vivo after subcutaneous injection within Matrigel plugs into SCID mice. Rapamycin decreased migration, proliferation and angiogenic properties of human and mouse islet-derived endothelial cell lines with appearance of apoptosis. The expression of angiogenesis-related factors VEGF, alphaVbeta3 integrin and thrombospondin-1 on islet endothelium was altered in the presence of rapamycin. On the other hand, rapamycin decreased the surface expression of molecules involved in immune processes such as ICAM-1 and CD40 and reduced the adhesion of T cells to islet endothelium. Our results suggest that rapamycin exerts dual effects on islet endothelium inducing a simultaneous inhibition of angiogenesis and a down-regulation of receptors involved in lymphocyte adhesion and activation.

Antiangiogenic and immunomodulatory effects of rapamycin on islet endothelium: relevance for islet transplantation

BIANCONE, Luigi;ROMAGNOLI, Renato;SALIZZONI, Mauro;CAVALLO PERIN, Paolo;SEGOLONI, Giuseppe;CAMUSSI, Giovanni
2006-01-01

Abstract

Donor intra-islet endothelial cells contribute to neovascularization after transplantation. Several factors may interfere with this process and ultimately influence islet engraftment. Rapamycin, a central immunosuppressant in islet transplantation, is an mTOR inhibitor that has been shown to inhibit cancer angiogenesis. The aim of this study was to evaluate the effects of rapamycin on islet endothelium. Rapamycin inhibited the outgrowth of endothelial cells from freshly purified human islets and the formation of capillary-like structures in vitro and in vivo after subcutaneous injection within Matrigel plugs into SCID mice. Rapamycin decreased migration, proliferation and angiogenic properties of human and mouse islet-derived endothelial cell lines with appearance of apoptosis. The expression of angiogenesis-related factors VEGF, alphaVbeta3 integrin and thrombospondin-1 on islet endothelium was altered in the presence of rapamycin. On the other hand, rapamycin decreased the surface expression of molecules involved in immune processes such as ICAM-1 and CD40 and reduced the adhesion of T cells to islet endothelium. Our results suggest that rapamycin exerts dual effects on islet endothelium inducing a simultaneous inhibition of angiogenesis and a down-regulation of receptors involved in lymphocyte adhesion and activation.
2006
6
11
2601
2611
Rapamycin
CANTALUPPI V; BIANCONE L; ROMANAZZI GM; FIGLIOLINI F; BELTRAMO S; GALIMI F; NINNIRI MS; ROMAGNOLI R; FRANCHELLO A; SALIZZONI M; PERIN PC; RICORDI C; SEGOLONI GP; CAMUSSI G
File in questo prodotto:
File Dimensione Formato  
cantaluppi 1.pdf

Accesso riservato

Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 576.59 kB
Formato Adobe PDF
576.59 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Antiangiogenic and immunomodulatory effects of rapamycin on islet endothelium. AMERICAN JOURNAL OF TRANSPLANTATION 2006; 6, p.2601-2611.pdf

Accesso riservato

Descrizione: Articolo principale
Tipo di file: PDF EDITORIALE
Dimensione 576.61 kB
Formato Adobe PDF
576.61 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/37186
Citazioni
  • ???jsp.display-item.citation.pmc??? 25
  • Scopus 59
  • ???jsp.display-item.citation.isi??? 61
social impact